HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. (HTGMQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
htgmq · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for HTG Molecular Diagnostics, Inc. (HTGMQ) measures how much investors pay for each dollar of the company's trailing earnings. HTGMQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$24.28.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2012 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
HTG Molecular Diagnostics, Inc.You HTGMQ | $0M | N/A | — | -$24.28 |
 Biocept, Inc. BIOCQ | $0M | N/A | — | -$56.78 |
 Brain Scientific Inc. BRSF | $0M | N/A | — | -$12.95 |
 Biostar Pharmaceuticals, Inc. BSPM | $0M | N/A | — | -$2.48 |
 Clever Leaves Holdings Inc. CLVR | $0M | N/A | — | -$11.42 |
 BC Craft Supply Co. Ltd. CRFTF | $0M | N/A | — | -$0.96 |
 Cue Health Inc. HLTHQ | $0M | N/A | — | -$2.44 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-24.28 | — | |
2021-12-31 FY2021 | — | $-29.66 | — | |
2020-12-31 FY2020 | — | $-54.12 | — | |
2019-12-31 FY2019 | — | $-91.17 | — | |
2018-12-31 FY2018 | — | $-107.61 | — | |
2017-12-31 FY2017 | — | $-322.05 | — | |
2016-12-31 FY2016 | — | $-658.95 | — | |
2015-12-31 FY2015 | — | $-852.43 | — | |
2014-12-31 FY2014 | — | $-345.53 | — | |
2013-12-31 FY2013 | — | $-291.34 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for HTG Molecular Diagnostics, Inc. (HTGMQ) measures how much investors pay for each dollar of the company's trailing earnings. HTGMQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$24.28.
Frequently asked questions
HTGMQ pe ratio · 6 questionsHTGMQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$24.28. Data sourced from Financial Modeling Prep via HTGMQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HTG Molecular Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09